Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Sanofi-Aventis |
---|---|
Information provided by: | Sanofi-Aventis |
ClinicalTrials.gov Identifier: | NCT00497783 |
The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Femina Delicata.
Condition | Intervention | Phase |
---|---|---|
Hygiene |
Drug: Lactoserum |
Phase IV |
Study Type: | Interventional |
Study Design: | Supportive Care, Open Label, Uncontrolled, Single Group Assignment, Safety Study |
Official Title: | Safety Dermatological Evaluation of the Acceptability With Gynecological Follow up for Dermacyd Femina Delicata |
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
The above information is not intended to contain considerations relevant to a patient's potential participation in a clinical trial.
Study ID Numbers: | LACTO_L_02949 |
Study First Received: | July 6, 2007 |
Last Updated: | May 19, 2008 |
ClinicalTrials.gov Identifier: | NCT00497783 History of Changes |
Health Authority: | Brazil: National Health Surveillance Agency |